ScholarLens Back to search
2000•Chinese Journal of New Drugs and Clinical RemediesRequires access

Evaluation of clinical therapeutic effect of cefepime in treating lower repiratory tract infections

Shu Sun

Open publisher page 0 citations

Abstract

AIM: To evaluate the efficacy of cefepime in the treatment of the lower respiratory tract infections. METHODS: Sixty eight patients were divided into two groups: cefepime group (36 patients) and ceftazidime group (32 patients). The above test and the control groups received cefepime and ceftazidime respectively, 2 g, iv, q 12 h for 8.2 d± s 2.6 d. RESULTS: The overall effective rates of cefepime and ceftazidime were 94 % and 91 %, respectively. The bacterial clearance rates were 93 % and 85 %, respectively. Both were without obvious adverse reactions. CONCLUSION: Cefepime is a safe and potent antibacterial agent in the treatment of the lower respiratory tract infections.

About this research paper

What this paper is about

AIM: To evaluate the efficacy of cefepime in the treatment of the lower respiratory tract infections. METHODS: Sixty eight patients were divided into two groups: cefepime group (36 patients) and ceftazidime group (32 patients). The above test and the control groups received cefepime and ceftazidime respectively, 2 g, iv, q 12 h for 8.2 d± s 2.6 d. RESULTS: The overall effective rates of cefepime and ceftazidime were 94 % and 91 %, respectively. The bacterial clearance rates were 93 % and 85 %, respectively. Both were without obvious adverse reactions. CONCLUSION: Cefepime is a safe and potent antibacterial agent in the treatment of the lower respiratory tract infections.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To evaluate the efficacy of cefepime in the treatment of the lower respiratory tract infections. METHODS: Sixty eight patients were divided into two groups: cefepime group (36 patients) and ceftazidime group (32 patients). The above test and the control groups received cefepime and ceftazidime respectively, 2 g, iv, q 12 h for 8.2 d± s 2.6 d. RESULTS: The overall effective rates of cefepime and ceftazidime were 94 % and 91 %, respectively. The bacterial clearance rates were 93 % and 85 %, respectively. Both were without obvious adverse reactions. CONCLUSION: Cefepime is a safe and potent antibacterial agent in the treatment of the lower respiratory tract infections.

Key concepts: Cefepime, Ceftazidime, Medicine, Respiratory tract infections, Adverse effect, Internal medicine, Respiratory tract, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Evaluation of clinical therapeutic effect of cefepime in treating lower repiratory tract infections — Research Paper | ScholarLens